Core Laboratories INC /DE/ 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
Core Laboratories Inc. reported a slight revenue increase in 2025, driven by service growth, but saw declines in net income and product sales amidst geopolitical conflicts and a challenging international exploration environment.
NYSE
Core Laboratories' 2024 10-K filing reveals a year of international growth offset by challenges in the U.S. onshore market, with a focus on reservoir description and production enhancement services.
NYSE
Core Laboratories Inc.'s 10-K filing provides a comprehensive overview of the company's business, financial performance, and potential risks, including details on its share structure and international operations.